Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. 1990

B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
Cullen Cardiovascular Surgical Research Laboratory, Texas Heart Institute, Houston.

Allograft coronary artery disease (CAD) is the major determinant of long-term survival following heart transplantation (HTx). In a group of 210 heart transplant recipients, we diagnosed CAD in 54 (27.1%) by coronary angiography, postmortem examination or examination of the transplanted heart at the time of retransplantation. Retrospective analysis of potential risk factors for the development of CAD was performed for both immunological (rejection pattern, immunosuppressive therapy, cytomegalovirus [CMV] infection), and nonimmunological (hyperlipidemia, smoking, hypertension, diabetes mellitus, obesity) risk factors. The total number of rejection episodes correlated significantly with the occurrence of CAD (P less than 0.05), showing that patients who experienced two or more rejection episodes had an incidence of CAD of 40%, as opposed to a 23% incidence in patients who experienced no rejection. A composite rejection score derived from multivariate regression analysis of the severity, frequency, and timing of acute cardiac rejection episodes was found to correlate with the development of CAD (P less than 0.05). Postoperative arterial hypertension also correlated significantly with the onset of CAD (P less than 0.01), with a 92.6% incidence of hypertension in the group with CAD versus 76.3% in the group without CAD. Smoking after transplantation correlated significantly with the occurrence of CAD (P less than 0.05). There was no significant correlation with other analyzed factors in this group of patients. In this review, the development of CAD after heart transplantation correlated with treated allograft rejection. Aggressive treatment of hypertension and cessation of smoking may contribute to alleviation of this serious complication.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
January 1992, Lancet (London, England),
B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
March 1995, Coronary artery disease,
B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
February 1996, The Medical journal of Australia,
B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
August 1995, The Medical journal of Australia,
B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
November 1988, The American journal of cardiology,
B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
February 1994, Coronary artery disease,
B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
January 1987, Transplantation reviews (Orlando, Fla.),
B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
August 2001, Clinical transplantation,
B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
October 1995, Transplantation proceedings,
B Radovancevic, and S Poindexter, and S Birovljev, and V Velebit, and H A McAllister, and J M Duncan, and D Vega, and J Lonquist, and C M Burnett, and O H Frazier
December 2011, The Cochrane database of systematic reviews,
Copied contents to your clipboard!